← Back to headlines
AbbVie Reports Strong Q1 Earnings, Performance Beyond Humira
Pharmaceutical giant AbbVie has announced robust first-quarter earnings, demonstrating strong financial performance even when excluding its blockbuster drug Humira. The company's diverse portfolio continues to contribute to its success.
7 May, 18:55 — 7 May, 18:55
Sources
Showing 1 of 1 sources
